J&J Formally Accepts $2.1 Billion Offer for Diabetes Device Unit

(Bloomberg) -- Johnson & Johnson said it will move forward with the $2.1 billion sale of its diabetes monitoring unit LifeScan Inc. to Platinum Equity, a private investment firm.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.